Ketobemidone

Ketobemidone

SCHEMBL28086319

CCC(=O)C1(c2cccc(O)c2)CCN(C)CC1.CCOC(=O)C1(c2ccccc2)CCN(C)CC1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of Ketobemidone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 6/20 0.72
OPRD1 P41143 3/20 0.72
OPRK1 P41145 3/20 0.72
SLC22A1 O15245 1/20 0.72
SLC6A4 P31645 1/20 0.72
ADRA1A P35348 1/20 0.72
KCNH2 Q12809 1/20 0.72
DRD3 P35462 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroxypethidine SCHEMBL29966554 0.91 OPRM1 (0.74) OPRM1OPRD1OPRK1SLC22A1SLC6A4
Hydroxypethidine SCHEMBL25246 0.91 OPRM1 (0.74) OPRM1OPRD1OPRK1SLC22A1SLC6A4
Hydroxypethidine SCHEMBL317328 0.90 OPRM1 (0.74) OPRM1OPRD1OPRK1SLC22A1SLC6A4
Ketobemidone SCHEMBL29565806 0.88 DRD3 (0.72) OPRM1OPRD1OPRK1SLC22A1SLC6A4
Ketobemidone SCHEMBL24574 0.88 DRD3 (0.72) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL12369084 0.87 OPRM1 (0.67) OPRM1OPRD1OPRK1SLC22A1SLC6A4
Ketobemidone SCHEMBL9706814 0.86 DRD3 (0.70) OPRM1OPRD1OPRK1SLC22A1SLC6A4
Meperidine SCHEMBL25431 0.85 OPRM1 (1.00) OPRM1OPRD1OPRK1SLC22A1SLC6A4
Meperidine SCHEMBL1083668 0.84 OPRM1 (1.00) OPRM1OPRD1OPRK1SLC22A1SLC6A4
Meperidine SCHEMBL2860723 0.84 OPRM1 (1.00) OPRM1OPRD1OPRK1SLC22A1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed